Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (AAVXF) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to 102.85%.

  • Abivax's EBITDA Margin rose 4093800.0% to 102.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 264.2%, marking a year-over-year change of. This contributed to the annual value of 1389.54% for FY2024, which is 13669200.0% up from last year.
  • Abivax's EBITDA Margin amounted to 102.85% in Q3 2025, which was up 4093800.0% from 886.14% recorded in Q2 2025.
  • Abivax's 5-year EBITDA Margin high stood at 142.06% for Q4 2024, and its period low was 886.14% during Q2 2025.